Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06776250
What this trial is testing

Study of How Safe and Effective Tarlatamab is in Brain Cancers

Who this might be right for
Astrocytic TumorOligodendroglial Tumor
University Health Network, Toronto 44
Large-scale testing (Phase 3)Study completedNCT00777153
What this trial is testing

Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
AstraZeneca 423
Testing effectiveness (Phase 2)Ended earlyNCT02047214
What this trial is testing

Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy

Who this might be right for
Glioblastoma Multiforme
Cortice Biosciences, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Early research (Phase 1)UnknownNCT02937844
What this trial is testing

Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Beijing Sanbo Brain Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03618667
What this trial is testing

GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

Who this might be right for
Glioblastoma, AdultEGFR Amplification
Samsung Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT00823459
What this trial is testing

Everolimus in Treating Patients With Recurrent Low-Grade Glioma

Who this might be right for
Adult Diffuse AstrocytomaAdult Mixed GliomaAdult Oligodendroglioma+2 more
Susan Chang 58
Early research (Phase 1)Looking for participantsNCT07480941
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
GlioblastomaHigh-grade GliomaMalignant Glioma+2 more
Beijing Biotech 36
Early research (Phase 1)Study completedNCT00498979
What this trial is testing

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Who this might be right for
Stage IV Melanoma
Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT03782415
What this trial is testing

Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM+1 more
MediciNova 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07431216
What this trial is testing

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Who this might be right for
Glioblastoma (GBM)
Starlight Therapeutics Inc. 68
Testing effectiveness (Phase 2)Study completedNCT01931098
What this trial is testing

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Who this might be right for
GlioblastomaGlioblastoma MultiformeGliosarcoma+2 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00006358
What this trial is testing

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Early research (Phase 1)Study completedNCT02010606
What this trial is testing

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+2 more
Cedars-Sinai Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT02315534
What this trial is testing

BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma

Who this might be right for
Glioblastoma
Sumitomo Pharma America, Inc. 34
Early research (Phase 1)Study completedNCT00003484
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Darell D. Bigner, MD, PhD 21
Testing effectiveness (Phase 2)Ended earlyNCT02060955
What this trial is testing

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

Who this might be right for
Glioblastoma Multiforme
CytoVac A/S 25
Testing effectiveness (Phase 2)Study completedNCT00039468
What this trial is testing

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center 26
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Next Page